Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea

Seung Young Kim, Sung Woo Jung, Jeong Han Kim, Ja Seol Koo, Hyung Joon Yim, Jong Jae Park, Hoon Jai Chun, Sang Woo Lee, Jai Hyun Choi

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    AIM: We compared three times daily dual therapy with standard triple therapy for effectiveness and safety in H.pylori infection. METHODS: Two hundred and four H.pylori positive patients with peptic ulcer were randomly assigned to one of two regimens: (i) triple therapy with amoxicillin, clarithromycin and lansoprazole twice daily for 2 weeks or (ii) dual therapy with amoxicillin and lansoprazole three times daily for 2 weeks. The success of eradication was evaluated 4 to 5 weeks after completing treatment. RESULTS: The eradication rate was 82.8% in the triple therapy group and 78.4% in the dual therapy group by per protocol analysis. This difference was not significant (P= 0.573). Adverse events were more frequent in the triple therapy group than in the dual therapy group (P= 0.002). CONCLUSIONS: Because dual therapy had fewer side effects than triple therapy and a similar eradication rate, dual therapy may provide an acceptable alternative first line therapy for H.pylori eradication in Korea.

    Original languageEnglish
    Pages (from-to)140-143
    Number of pages4
    JournalBritish Journal of Clinical Pharmacology
    Volume73
    Issue number1
    DOIs
    Publication statusPublished - 2012 Jan

    Keywords

    • Amoxicillin/administration and dosage
    • Combination
    • Drug therapy
    • Helicobacter pylori/drug therapy
    • Proton pump inhibitors/administration and dosage

    ASJC Scopus subject areas

    • Pharmacology
    • Pharmacology (medical)

    Fingerprint

    Dive into the research topics of 'Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea'. Together they form a unique fingerprint.

    Cite this